119
Views
1
CrossRef citations to date
0
Altmetric
Articles

The MX2Lx matrices, with M = Zn2+, Cd2+, Hg2+, X = Cl, Br, I and L = pyrazine, quinoxaline, phenazine

&
Pages 676-695 | Received 19 Apr 2016, Accepted 03 Oct 2016, Published online: 04 Dec 2016
 

Abstract

Three structures combining the ditopic organic ligand quinoxaline with divalent metal halides MX2, with M = Cd2+ and Hg2+, are reported. All three structures are coordination polymers, with the quinoxaline ligand acting as organic linker between metal centers. In two structures, with M = Hg2+ and X = Cl or Br, the formation of a 1-D, halide-bridged polymer in addition to the quinoxaline coordination polymer increases the dimensionality of the structure to 2-D, while in the case of M = Hg2+ and X = Cl, the formation of two halide-bridged polymers along with the coordination polymer results in the creation of a 3-D structure. Structural trends are identified, and the templating effect of the organic ligand is highlighted, through horizontal and vertical comparisons of these structures with related structures reported in the literature obtained upon combining the said metal halides with the related organic ligands pyrazine, quinoxaline, and phenazine, presented as the resulting matrices of structures.

Acknowledgements

The authors would like to thank Peet van Rooyen and Dave Liles for assistance with crystallographic aspects of this study.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.